Shvartsman HS - Search Results

1

Overexpression of kallikrein 10 in epithelial ovarian carcinomas.

Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Wolf JK, Mills GB, Bast RC Jr, Gershenson DM, Schmandt R. Shvartsman HS, et al. Gynecol Oncol. 2003 Jul;90(1):44-50. doi: 10.1016/s0090-8258(03)00257-9. Gynecol Oncol. 2003. PMID: 12821340

2

The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.

Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF, Gershenson DM. Brown J, et al. Among authors: shvartsman hs. Gynecol Oncol. 2005 May;97(2):489-96. doi: 10.1016/j.ygyno.2005.01.011. Gynecol Oncol. 2005. PMID: 15863149

3

Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.

Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM. Shvartsman HS, et al. Gynecol Oncol. 2007 Jun;105(3):625-9. doi: 10.1016/j.ygyno.2007.01.030. Epub 2007 Feb 22. Gynecol Oncol. 2007. PMID: 17320156

4

beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.

Lee CM, Shvartsman H, Deavers MT, Wang SC, Xia W, Schmandt R, Bodurka DC, Atkinson EN, Malpica A, Gershenson DM, Hung MC, Lu KH. Lee CM, et al. Gynecol Oncol. 2003 Mar;88(3):363-8. doi: 10.1016/s0090-8258(02)00015-x. Gynecol Oncol. 2003. PMID: 12648588

5

The activity of taxanes in the treatment of sex cord-stromal ovarian tumors.

Brown J, Shvartsman HS, Deavers MT, Burke TW, Munsell MF, Gershenson DM. Brown J, et al. Among authors: shvartsman hs. J Clin Oncol. 2004 Sep 1;22(17):3517-23. doi: 10.1200/JCO.2004.12.074. J Clin Oncol. 2004. PMID: 15337800

6

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.

Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM. Wong KK, et al. Among authors: shvartsman hs. Int J Gynecol Pathol. 2007 Oct;26(4):404-9. doi: 10.1097/pgp.0b013e31803025cd. Int J Gynecol Pathol. 2007. PMID: 17885490

7

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.

Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM. Schmandt RE, et al. Cancer. 2003 Aug 15;98(4):758-64. doi: 10.1002/cncr.11561. Cancer. 2003. PMID: 12910520 Free article.

8

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

9

Use of a vacuum-assisted closure device in the treatment of recurrent Paget's disease of the vulva.

Shvartsman HS, Langstein H, Worley C, Malpica A, Ramondetta LM. Shvartsman HS, et al. Obstet Gynecol. 2003 Nov;102(5 Pt 2):1163-6. doi: 10.1016/s0029-7844(03)00716-6. Obstet Gynecol. 2003. PMID: 14607043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters